| Breakdown | TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 28.21B | 28.37B | 27.18B | 26.52B | 25.79B | 23.06B |
| Gross Profit | 13.75B | 13.81B | 12.90B | 12.38B | 11.99B | 10.91B |
| EBITDA | 9.89B | 9.65B | 8.79B | 8.46B | 8.26B | 7.39B |
| Net Income | 7.84B | 7.00B | 7.18B | 6.86B | 6.53B | 5.89B |
Balance Sheet | ||||||
| Total Assets | 37.64B | 36.30B | 34.41B | 30.73B | 26.73B | 25.82B |
| Cash, Cash Equivalents and Short-Term Investments | 8.51B | 8.57B | 9.47B | 6.87B | 2.58B | 5.46B |
| Total Debt | 7.19B | 7.05B | 6.61B | 6.00B | 5.83B | 5.75B |
| Total Liabilities | 15.93B | 15.88B | 15.41B | 14.38B | 14.53B | 13.58B |
| Stockholders Equity | 21.72B | 20.41B | 19.00B | 16.35B | 12.19B | 12.25B |
Cash Flow | ||||||
| Free Cash Flow | 6.19B | 5.70B | 7.49B | 7.59B | 4.61B | 4.77B |
| Operating Cash Flow | 8.72B | 7.96B | 8.68B | 8.70B | 5.40B | 5.44B |
| Investing Cash Flow | -2.67B | -2.78B | -2.33B | -1.53B | -1.36B | -1.22B |
| Financing Cash Flow | -5.12B | -5.98B | -4.47B | -3.03B | -7.04B | -4.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | $223.81B | 40.12 | 89.07% | 0.58% | 13.43% | 28.40% | |
81 Outperform | $530.06B | 39.94 | 51.97% | 0.63% | 18.56% | 26.42% | |
81 Outperform | $323.36B | 34.22 | 65.79% | 0.56% | 26.53% | 47.73% | |
72 Outperform | $310.60B | 31.26 | 38.90% | 0.69% | 2.15% | 27.46% | |
71 Outperform | $52.82B | 27.09 | 29.72% | 0.24% | 30.33% | 51.65% | |
68 Neutral | $72.86B | 26.48 | 12.81% | 2.29% | 15.55% | 43.35% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |